EarningsTECHNODRUG
TECHNODRUG Earnings Update
Announcement summary
- What happened
- TECHNODRUG published a corporate disclosure on 30 April 2026. Read the full announcement for details.
- Company
- Techno Drugs Ltd.
- Announcement published
Original announcement
(Q3 Un-audited): EPS was Tk. 0.31 for January-March 2026 as against Tk. 0.33 for January-March 2025; EPS was Tk. 1.18 for July 2025-March 2026 as against Tk. 1.41 for July 2024-March 2025. NOCFPS was Tk. 1.62 for July 2025-March 2026 as against Tk. 0.15 for July 2024-March 2025. NAV per share with revaluation was Tk. 31.38 as on March 31, 2026, and Tk. 30.58 as on June 30, 2025. NAV per share without revaluation was Tk. 27.69 as on March 31, 2026, and Tk. 26.88 as on June 30, 2025. (cont.)
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 69f2d0f0f35b0b05d2cd35b5
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from TECHNODRUG
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.